港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

728.939

-15.659-2.10%

涨家数：14

跌家数：18

平家数：2

市盈率：- -

高：744.967

开：744.496

低：723.794

收：744.598

数据加载中...

再鼎医药将于8月7日举行董事会会议以审批中期业绩

打造全球创新药械首发地！到2027年，浦东生物医药产业规模将突破5000亿元

亚盛医药-B完成先旧后新配售2200万股股份净筹约14.925亿港元

亚盛医药-B(06855.HK)完成先旧后新配售2200万股股份净筹约14.925亿港元

心玮医疗-B(06609)：姜雪获委任为监事委员会主席

白云山(00874.HK)子公司中期票据和超短期融资券获准注册

AI打破医药“双十魔咒”，中国创新药迎来超车时刻

东曜药业-B(01875)：英文股份简称将更改为“BIODLINK-B”

恒瑞医药(01276.HK)拟4001.44 万元收购控股子公司成都盛迪1.4587%股权

广生堂(300436.SZ)：乙肝治疗一类创新药奈瑞可韦GST-HG141的III期临床试验首例受试者成功入组

普利制药退市不影响索赔，此类投资者还可加入

辉瑞制药和BioNTech的更新版新冠疫苗获欧洲药品管理局积极意见

康诺亚-B07月25日主力净流出325.5万元散户资金买入

腾盛博药-B07月25日主力净流出84.8万元散户资金买入

基石药业-B07月25日主力净流出754.0万元散户资金买入

启明医疗-B07月25日主力净流出35.8万元散户资金买入

华领医药-B07月25日遭主力抛售365.2万元

德琪医药-B07月25日获主力加仓508.9万元

康方生物07月25日主力净流出4030.2万元散户资金买入

归创通桥07月25日主力净流入129.4万元散户资金抛售

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1574/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":728.93866,"timestamp":1753430886241,"preClose":744.5975,"halted":0,"volume":295989198,"delay":0,"changeRate":-0.02103,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-15.658813,"latestTime":"07-25 16:00:00","open":744.49634,"high":744.967,"low":723.794,"amount":7101826928,"amplitude":0.028435,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753407000000,1753416000000],[1753419600000,1753430400000]],"pbRate":5.862148,"peRate":-36.113023,"turnoverRate":0.011111,"increases":13,"decrements":20,"flats":0,"marketCap":427345468672,"floatMarketCap":392843141040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":744.967,"amplitude":0.028435,"preClose":744.5975,"low":723.794,"pbRate":"5.862148","latestPrice":728.93866,"volume":295989198,"delay":0,"open":744.49634,"prevYearClose":331.1933,"prevWeekClose":711.682,"prevMonthClose":555.617,"prevQuarterClose":555.617,"fiveDayClose":711.682,"twentyDayClose":566.494,"sixtyDayClose":466.153,"secType":"PLATE","market":"HK","turnoverRate":0.011111,"peRate":-36.113023,"marketCap":427345468672,"floatMarketCap":392843141040,"timestamp":1753430886241,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":14,"down":18,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554279507","title":"再鼎医药将于8月7日举行董事会会议以审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2554279507","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554279507?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 22:44","pubTimestamp":1753454640,"startTime":"0","endTime":"0","summary":"格隆汇7月25日丨再鼎医药(09688.HK)公告，董事会审核委员会将于2025年8月7日(星期四)审议及批准(其中包括)根据美国公认会计准则及美国证券交易委员会的适用规则编制的公司及其附属公司截至2025年6月30日止3个月及6个月的未经审核中期业绩及其发布。倘业绩获审核委员会批准，公司将于2025年8月7日(星期四)在香港联合交易所有限公司网站www.hkexnews.hk及公司网站www.zailaboratory.com发布业绩公告。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725224730a6c1ecfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725224730a6c1ecfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","LU2488822045.USD","BK1574","ZLAB","BK1161","BK1588"],"gpt_icon":0},{"id":"2554760776","title":"打造全球创新药械首发地！到2027年，浦东生物医药产业规模将突破5000亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554760776","media":"浦东发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554760776?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 20:58","pubTimestamp":1753448317,"startTime":"0","endTime":"0","summary":"7月25日下午，浦东召开新闻通气会，介绍近期出台的《浦东新区生物医药产业园区功能提升方案》总体情况。2024年浦东拥有30余项海外授权，交易额占全国30%。此次方案中，首次提出了打造全球创新药械首发地，是因为看到了“3F”创新产品正逐步出现，而对于这些“好苗子”，需要进一步挖掘临床价值，让好药在浦东实现创新的同时，加快实现创收。浦东新区科技和经济委员会有关负责人表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725212014a6c1cff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725212014a6c1cff0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02552","BK1191","BK1574"],"gpt_icon":0},{"id":"2554937107","title":"亚盛医药-B完成先旧后新配售2200万股股份 净筹约14.925亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554937107","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554937107?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 20:44","pubTimestamp":1753447440,"startTime":"0","endTime":"0","summary":"配售代理已根据配售及认购协议的条款及条件按配售价每股销售股份68.60港元向不少于六名承配人成功配售合共2200万股销售股份。由于所有认购事项先决条件亦已获达成，公司已于2025年7月25日向卖方以每股认购股份68.60港元配发及发行2200万股认购股份，净筹约14.925亿港元，拟用于商业化工作，包括扩大覆盖范围和提高患者就医机会;全球临床开发，以推进公司的核心管线在研产品;基础设施及营运资金以加强全球营运。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725204638a46367e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725204638a46367e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2554109767","title":"亚盛医药-B(06855.HK)完成先旧后新配售2200万股股份 净筹约14.925亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554109767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554109767?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 20:35","pubTimestamp":1753446958,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK1161","AAPG","06855","BK1574"],"gpt_icon":0},{"id":"2554767485","title":"心玮医疗-B(06609)：姜雪获委任为监事委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2554767485","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554767485?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 20:32","pubTimestamp":1753446773,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，公司于2025年7月25日举行雇员代表会议，并选举刘红宝先生为公司第二届监事委员会的雇员代表监事。于同日，刘柏巍先生因个人工作安排而辞任公司监事，并不再履行雇员代表监事及监事委员会主席职务。此外，姜雪女士已获委任为第二届监事委员会主席，自2025年7月25日起生效，直至第二届监事委员会任期届满为止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06609","BK1574","BK1100"],"gpt_icon":0},{"id":"2554842762","title":"白云山(00874.HK)子公司中期票据和超短期融资券获准注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2554842762","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554842762?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 19:53","pubTimestamp":1753444381,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["601988","LU0293314216.USD","IE00BQJZWZ67.USD","SG9999001093.SGD","LU1282651121.HKD","LU1497733557.USD","LU1634259391.SGD","BK0012","BK0070","LU2097828805.USD","LU1282651048.USD","BK1606","BK1521","LU0348805143.USD","IE00BWDBJ730.SGD","LU2097828557.USD","LU0651946864.USD","LU1224444064.USD","BK0239","LU1634259557.SGD","BK0188","BK1197","LU2097828474.EUR","LU1051768304.USD","LU1515016050.SGD","159938","03988","LU1522347837.USD","LU0307460666.USD","LU0651947912.USD","LU2097828631.EUR","LU1497733631.SGD","BK0196","LU1497734951.SGD","BK0028","00874","03143","LU2097828714.EUR","LU1048588211.SGD","09939","BK0183","BK1231","LU0588546209.SGD","SG9999006597.SGD","BK0015","600332","BK1191","BK0097","BK1515","BK1574"],"gpt_icon":0},{"id":"2554646527","title":"AI打破医药“双十魔咒”，中国创新药迎来超车时刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2554646527","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554646527?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 19:28","pubTimestamp":1753442908,"startTime":"0","endTime":"0","summary":"据全球知名投资机构ARK估算，AI可将新药研发成本降低85%，时间缩短40%。中国的“弯道超车”底气在这场全球竞赛中，中国凭借独特的优势，有望在“AI+创新药”领域实现“弯道超车”。这些本土药企的突破，正让中国创新药的成长逻辑愈发清晰。未来，随着技术持续突破和行业生态不断完善，我国有望在AI驱动的新一轮医药创新浪潮中占据重要位置，为全球患者带来更多“中国智造”的创新药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1753345767739497496","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","09939","BK1574","BK1515","06978"],"gpt_icon":0},{"id":"2554167769","title":"东曜药业-B(01875)：英文股份简称将更改为“BIODLINK-B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2554167769","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554167769?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 18:49","pubTimestamp":1753440587,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东曜药业-B(01875)公布，公司用作于联交所买卖股份的英文股份简称将由“TOT BIOPHARM-B”更改为“BIODLINK-B”，自2025年7月30日上午九时正起生效。公司中文股份简称“东曜药业-B”及股份代号“1875”维持不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"2554765228","title":"恒瑞医药(01276.HK)拟4001.44 万元收购控股子公司成都盛迪1.4587%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2554765228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554765228?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 18:07","pubTimestamp":1753438055,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["600276","LU1997245177.USD","BK0012","LU2488822045.USD","09939","159938","01276","LU1064130708.USD","BK1515","LU2495084118.USD","LU1064131003.USD","LU1655091616.SGD","LU2148510915.USD","BK1191","BK1161","LU1997245094.SGD","LU0405327148.USD","BK0060","BK0239","LU1969619763.USD","LU2328871848.SGD","LU1328615791.USD","BK0188","BK0196","BK1574","BK0183","LU1997244956.HKD","LU0405327494.USD","BK0028"],"gpt_icon":0},{"id":"2554630017","title":"广生堂(300436.SZ)：乙肝治疗一类创新药奈瑞可韦GST-HG141的III期临床试验首例受试者成功入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2554630017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554630017?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 17:51","pubTimestamp":1753437067,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广生堂 发布公告，公司创新药控股子公司福建广生中霖生物科技有限公司的在研乙肝治疗一类创新药奈瑞可韦GST-HG141的III期临床试验，已于2025年7月25日在树兰(杭州)医院完成首例受试者成功入组给药。2024年11月，GST-HG141的II期临床研究成果被全球肝病研究领域的权威专业学术机构美国肝病研究协会作为最新突破摘要形式接受并展示。2024年12月，GST-HG141被国家药品监督管理局药品审评中心纳入突破性治疗品种名单。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","BK1161","III","GST","BK4134","BK0239","03347","300436","BK1574","BK1583","BK1576","BK1141","06978"],"gpt_icon":0},{"id":"2554106766","title":"普利制药退市不影响索赔，此类投资者还可加入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554106766","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554106766?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:19","pubTimestamp":1753431540,"startTime":"0","endTime":"0","summary":"　　关于普利制药索赔案部分投资者已收到核损报告，现案件已在逐步推进中。上海沪紫律师事务所刘鹏律师表示现仍在征集受损投资者中。回溯此案，2025年3月21日，公司收到证监会的处罚决定，因财务造假极其严重触及重大违法强制退市，该公司已在4月正式告别A股，但公司主体仍在运转，不影响投资者索赔事宜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2025-07-25/doc-infhsmtw8320094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01477","BK1191","BK1574"],"gpt_icon":0},{"id":"2554843763","title":"辉瑞制药和BioNTech的更新版新冠疫苗获欧洲药品管理局积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2554843763","media":"英为财情","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554843763?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:17","pubTimestamp":1753431420,"startTime":"0","endTime":"0","summary":"Investing.com -- 辉瑞制药( Pfizer )(NYSE:PFE)和BioNTech(NASDAQ:BNTX)的LP.8.1适应型单价新冠疫苗已获得欧洲药品管理局人用药品委员会(CHMP)的积极意见。\n根据两家公司发布的声明，该推荐适用于6个月及以上年龄的个体。\nCHMP的建议现将由欧盟委员会审核，预计欧盟委员会将很快就该更新版疫苗作出最终决定。\n\n本文由人工智能协助翻译。更多信息，请参见我们的使用条款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/stock-market-news/article-93CH-2902956","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["IE00B19Z3581.USD","LU1066051498.USD","159646","BK4568","SG9999001176.SGD","01477","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225284248.USD","BK1191","LU0985481810.HKD","LU1057294990.SGD","SG9999003800.SGD","LU0456855351.SGD","LU1883839398.USD","LU1894683264.USD","LU0321505868.SGD","LU1066053197.SGD","BK4599","IE00BLSP4452.SGD","BK1574","BK4581","LU0122379950.USD","LU1894683348.USD","BK4592","LU0058720904.USD","IE0002270589.USD","BK4585","LU0868494617.USD","IE000M9KFDE8.USD","BK4534","PFE","BK4588","SG9999011175.SGD","BK4533","SG9999002232.USD","BK4007","BK4550","LU0306806265.USD","SGXZ57979304.SGD","SG9999001176.USD","SG9999002224.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0289739699.SGD","LU0225771236.USD","LU0321505439.SGD","LU1023059063.AUD","LU0306807586.USD"],"gpt_icon":0},{"id":"2554767546","title":"康诺亚-B07月25日主力净流出325.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554767546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554767546?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:16","pubTimestamp":1753431362,"startTime":"0","endTime":"0","summary":"07月25日, 康诺亚-B股价跌3.24%，报收59.65元，成交金额3.0亿元，换手率1.68%，振幅5.68%，量比0.93。康诺亚-B今日主力资金净流出325.5万元，上一交易日主力净流入2726.6万元。该股近5个交易日上涨2.61%，主力资金累计净流入4166.6万元；近20日主力资金累计净流入1.2亿元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725170020a462ff13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725170020a462ff13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","BK1583","02162"],"gpt_icon":0},{"id":"2554760694","title":"腾盛博药-B07月25日主力净流出84.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554760694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554760694?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:16","pubTimestamp":1753431362,"startTime":"0","endTime":"0","summary":"07月25日, 腾盛博药-B股价跌1.49%，报收1.99元，成交金额1207.1万元，换手率0.83%，振幅5.45%，量比0.61。腾盛博药-B今日主力资金净流出84.8万元，上一交易日主力净流入169.8万元。该股近5个交易日下跌2.45%，主力资金累计净流入249.2万元；近20日主力资金累计净流入440.1万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725170021a6c15c32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725170021a6c15c32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02137","BK1161","BK1574"],"gpt_icon":0},{"id":"2554241767","title":"基石药业-B07月25日主力净流出754.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554241767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554241767?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:16","pubTimestamp":1753431360,"startTime":"0","endTime":"0","summary":"07月25日, 基石药业-B股价跌0.92%，报收7.51元，成交金额1.0亿元，换手率0.93%，振幅5.15%，量比0.86。基石药业-B今日主力资金净流出754.0万元，上一交易日主力净流入63.8万元。该股近5个交易日上涨14.31%，主力资金累计净流出2229.9万元；近20日主力资金累计净流出2253.4万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165945a462fec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165945a462fec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2554076755","title":"启明医疗-B07月25日主力净流出35.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554076755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554076755?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:15","pubTimestamp":1753431349,"startTime":"0","endTime":"0","summary":"07月25日, 启明医疗-B股价跌2.08%，报收2.82元，成交金额1486.2万元，换手率1.18%，振幅5.21%，量比1.13。启明医疗-B今日主力资金净流出35.8万元，上一交易日主力净流入257.7万元。该股近5个交易日上涨4.89%，主力资金累计净流入581.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入583.2万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165554a6c15996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165554a6c15996&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02500","BK1574","BK1100"],"gpt_icon":0},{"id":"2554183793","title":"华领医药-B07月25日遭主力抛售365.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554183793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554183793?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:15","pubTimestamp":1753431346,"startTime":"0","endTime":"0","summary":"07月25日，华领医药-B股价收平报3.83元，成交金额2966.0万元，换手率0.74%，振幅5.74%，量比0.63。华领医药-B今日主力资金净流出365.2万元，连续4日净流出，上一交易日主力净流出278.8万元。该股近5个交易日下跌5.43%，主力资金累计净流出1473.3万元；近20日主力资金累计净流入4009.7万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165436a462fc0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165436a462fc0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02552","BK1191","BK1574"],"gpt_icon":0},{"id":"2554763497","title":"德琪医药-B07月25日获主力加仓508.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554763497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554763497?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:15","pubTimestamp":1753431344,"startTime":"0","endTime":"0","summary":"07月25日, 德琪医药-B股价涨9.13%，报收5.38元，成交金额8593.8万元，换手率2.38%，振幅11.76%，量比1.44。德琪医药-B今日主力资金净流入508.9万元，连续4日净流入，上一交易日主力净流入312.6万元。该股近5个交易日上涨20.36%，主力资金累计净流入1412.7万元；近20日主力资金累计净流入2969.7万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165354a6c158a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165354a6c158a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06996","BK1191","BK1574"],"gpt_icon":0},{"id":"2554976320","title":"康方生物07月25日主力净流出4030.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554976320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554976320?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:15","pubTimestamp":1753431341,"startTime":"0","endTime":"0","summary":"07月25日, 康方生物股价跌2.93%，报收149.10元，成交金额12.1亿元，换手率0.90%，振幅4.56%，量比0.66。康方生物今日主力资金净流出4030.2万元，上一交易日主力净流入1.3亿元。该股近5个交易日上涨6.61%，主力资金累计净流入1.3亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4.3亿元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165247a6c157f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165247a6c157f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","BK1161","LU0348784397.USD","LU1794554557.SGD","LU1720050803.USD","IE00B543WZ88.USD","LU0348783233.USD","BK1574","LU2488822045.USD","IE00B5MMRT66.SGD","09926","LU0417516571.SGD"],"gpt_icon":0},{"id":"2554764785","title":"归创通桥07月25日主力净流入129.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2554764785","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554764785?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 16:15","pubTimestamp":1753431329,"startTime":"0","endTime":"0","summary":"07月25日, 归创通桥股价涨2.01%，报收22.80元，成交金额2177.3万元，换手率0.30%，振幅5.82%，量比1.21。归创通桥今日主力资金净流入129.4万元，上一交易日主力净流出301.8万元。该股近5个交易日上涨7.62%，主力资金累计净流出189.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出57.8万元，其中净流出天数为5日。该股主力净额占比0.02%，港股市场排名282/2673。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725164909a462f933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725164909a462f933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1583","BK1574","BK1100","02190"],"gpt_icon":0}],"pageSize":20,"totalPage":33,"pageCount":1,"totalSize":649,"code":"91000000","status":"200"}]}}